Drug Approval | November 26, 2021
Aadi Bioscience secures U.S FDA approval of its first product Fyarro
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
The approval is for Cytomegalovirus, a type of Herpes virus
Officials from ACG signed the MoU with the Maharashtra government for the Rs 600 crore investment in the backward region of Marathwada
In his new role as Managing Director India and Global Head, Partnerships and Innovative Finance, Singh will oversee the financial, human, and operational functions of the India office
Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE)
Obseva announced previously that the company has entered into a partnership with Syneos Health to support commercialization of linzagolix in the US and EU
Subscribe To Our Newsletter & Stay Updated
